Treating Dyslipidemias in the Primary Prevention of Atherosclerotic Cardiovascular Disease in Older Adults with Diabetes Mellitus

被引：5

作者：

Tan, MengHee ^{[1
]}

MacEachern, Mark Paul ^{[2
]}

机构：

[1] Univ Michigan, Dept Internal Med, Div Metab Endocrinol & Diabet, 24 Frank Lloyd Wright Dr, Ann Arbor, MI 48105 USA

[2] Univ Michigan, Taubman Hlth Sci Lib, 1135 Catherine St, Ann Arbor, MI 48109 USA

来源：

CLINICS IN GERIATRIC MEDICINE | 2020年 / 36卷 / 03期

关键词：

Older people with diabetes; Dyslipidemias; Primary prevention; Cardiovascular disease; CORONARY-HEART-DISEASE; LOWERING LDL CHOLESTEROL; VASCULAR-DISEASE; ARTERY-DISEASE; ATHEROGENIC INDEX; INDIVIDUAL DATA; STATIN THERAPY; RISK; MORTALITY; METAANALYSIS;

D O I：

10.1016/j.cger.2020.04.006

中图分类号：

R592 [老年病学]; C [社会科学总论];

学科分类号：

03 ; 0303 ; 100203 ;

摘要：

People with diabetes mellitus (DM), especially those who are older, are at higher risk for premature morbidity and mortality related to atherosclerotic cardiovascular disease (ASCVD). Clinical practice guidelines recommend statin therapy for people with DM ages 40 to 75 years. The evidence for those greater than 75 years of age is relatively limited at present. Other health problems should be considered when planning ASCVD primary prevention in adults ages greater than 75 years with DM. Clinicians should discuss the risks and benefits of each plan with these patients and their caregivers.

引用

页码：457 / +

页数：21

共 66 条

[1] Safety and efficacy of statin therapy [J].

Adhyaru, Bhavin B. ;

Jacobson, Terry A. .

NATURE REVIEWS CARDIOLOGY, 2018, 15 (12) :757-769

[2] The independent effect of type 2 diabetes mellitus on ischemic heart disease, stroke, and death - A population-based study of 13000 men and women with 20 years of follow-up [J].

Almdal, T ;

Scharling, H ;

Jensen, JS ;

Vestergaard, H .

ARCHIVES OF INTERNAL MEDICINE, 2004, 164 (13) :1422-1426

[3]

American Diabetes Association, 2019, Diabetes Care, V42, pS103, DOI 10.2337/dc19-S010

[4]

[Anonymous], 2017, National Diabetes Statistics Report, P20

[5]

Arnett DK, 2019, J AM COLL CARDIOL, V74, pE177, DOI 10.1016/j.jacc.2019.03.010

[6] Cardiovascular Risk Reduction with Icosapent Ethyl for Hypertriglyceridemia [J].

Bhatt, Deepak L. ;

Steg, P. Gabriel ;

Miller, Michael ;

Brinton, Eliot A. ;

Jacobson, Terry A. ;

Ketchum, Steven B. ;

Doyle, Ralph T., Jr. ;

Juliano, Rebecca A. ;

Jiao, Lixia ;

Granowitz, Craig ;

Tardif, Jean-Claude ;

Ballantyne, Christie M. .

NEW ENGLAND JOURNAL OF MEDICINE, 2019, 380 (01) :11-22

[7] Intensive versus moderate lipid lowering with statins after acute coronary syndromes [J].

Cannon, CP ;

Braunwald, E ;

McCabe, CH ;

Rader, DJ ;

Rouleau, JL ;

Belder, R ;

Joyal, SV ;

Hill, KA ;

Pfeffer, MA ;

Skene, AM .

NEW ENGLAND JOURNAL OF MEDICINE, 2004, 350 (15) :1495-1504

[8]

Chaudhary A, 2017, GASTROENTEROL RES, V10, P190, DOI 10.14740/gr762e

[9]

Cholesterol Treatment Trialists' (CTT) Collaborators, 2015, LANCET, V376, P1670

[10] Non-invasive screening for coronary artery disease in asymptomatic diabetic patients: a systematic review and meta-analysis of randomised controlled trials [J].

Clerc, Olivier F. ;

Fuchs, Tobias A. ;

Stehli, Julia ;

Benz, Dominik C. ;

Grani, Christoph ;

Messerli, Michael ;

Giannopoulos, Andreas A. ;

Buechel, Ronny R. ;

Luscher, Thomas F. ;

Pazhenkottil, Aju P. ;

Kaufmann, Philipp A. ;

Gaemperli, Oliver .

EUROPEAN HEART JOURNAL-CARDIOVASCULAR IMAGING, 2018, 19 (08) :838-846

← 1 2 3 4 5 6 7 →